The latest trading session saw Gilead Sciences (GILD) ending at $79.48, denoting a +1.34% adjustment from its last day's close. The stock's performance was ahead of the S&P 500's daily gain of 0.29%. At the same time, the Dow lost 0.25%, and the tech-heavy Nasdaq gained 0.43%. The HIV and hepatitis C drugmaker's shares have seen a decrease of 1.54% over the last month, not keeping up with the Medical sector's gain of 2.29% and the S&P 500's gain of 2.08%. The investment community will be paying close attent ...